PDCD1 and non-small cell lung carcinoma: As supported, the pleural space in NSCLC represents an extension of the tumor microenvironment, and PD-1 mAb can serve as a potent stimulatory agent to counteract the tumor-mediated immune tolerance and T-cell exhaustion.